Wywiady

Impact of the SPRINT trial on the future guidelines

Rola spotkań lekarzy hipertensjologów z Europy i wymiany ich doświadczeń podczas międzynarodowych kongresów

Development of new ambulatory blood pressure measurement techniques

Implementation of novel echocardiographic parameters into clinical practice and CV-guidelines

CV risk factors and CVD in women. 2. Do we need guidelines update?

How can we improve blood pressure control and other CV risk factors?
Should we talk to governments in order to deal with the problem?
What about programs for children?

Implications of new trials in diabetes on cardiovascular protection

Using genetic studies to improve cardiovascular protection

Primary hyperaldosteronism - time for reappraisal of guidelines?

Target blood presure values after SPRINT study - time for reconsideration?